Abstract:Adrenomedullin (ADM) and proadrenomedullin N-terminal 20 peptide (PAMP) are widely distributed in various body tissues and organs, including the hypothalamo-pituitary-adrenal (HPA) axis. ADM and PAMP inhibit in vitro release of ACTH from pituitary corticotropes, and findings suggest that this effect may become relevant when an exceedingly high ACTH secretion must be counteracted. ADM directly supresses angiotensin-II- and K+-stimulated aldosterone secretion from ZG cells, acting through calcitonin gene-related peptide (CGRP) type 1 ADM(22-52)-sensitive receptors, the activation of which is likely to impair Ca2+ influx. In contrast, ADM stimulates medullary chromaffin cells to release catecholamines, which in turn enhance aldosterone secretion acting in a paracrine manner. Also this effect of ADM occurs via CGRP1 receptors, which are coupled with the adenylate cyclase-dependent cascade. There is indication that in vivo these two opposite effects of ADM on ZG may interact with each other when normal aldosterone secretion has to be restored. ADM exerts a mitogenic effect on rat ZG, acting via CGRP1 receptors that activate the tyrosine kinase-dependent mitogen-activated protein kinase cascade. These findings, along with the demonstration of a high level of ADM gene expression in adrenocortical adenomas and carcinomas, may suggest a role for ADM as adrenocortical growth stimulator and tumor promoter. PAMP, like ADM, suppresses aldosterone response of ZG cells to Ca2+-dependent agonists, but, in contrast with ADM, it inhibits catecholamine release by adrenal medulla. Both effects of PAMP are mediated by PAMP(12-20)-sensitive receptors, whose signaling mechanism is likely to involve the blockade of voltage-gated Ca2+ channels. The concentrations attained by ADM and PAMP in the blood rule out the possibility that they act as true circulating hormones. Conversely, their content in the hypothalamo-pituitary complex and adrenal gland is consistent with a paracrine mechanism of action, which may play an important role in pathophysiological conditions where the function of the HPA axis has to be reset.

Induction of Preprotachykinin-I and Neurokinin-1 by Adrenocorticotropin and Prolactin. Implication for Neuroendocrine-Immune-hematopoietic Axis

Cloning of Human Preprotachykinin-I Promoter and the Role of Cyclic Adenosine 5 '-Monophosphate Response Elements in Its Expression by Il-1 and Stem Cell Factor

Effects of Preprotachykinin‐I Peptides on Hematopoietic Homeostasis: A Role for Bone Marrow Endopeptidases

Crosstalk Between Neurokinin Receptors is Relevant to Hematopoietic Regulation: Cloning and Characterization of Neurokinin-2 Promoter

Increased Expression of Preprotachykinin-I and Neurokinin Receptors in Human Breast Cancer Cells: Implications for Bone Marrow Metastasis.

Differences in the Expression of Neurokinin Receptor in Neural and Bone Marrow Mesenchymal Cells: Implications for Neuronal Expansion from Bone Marrow Cells

The Dynamics of Bone Marrow Stromal Cells in the Proliferation of Multipotent Hematopoietic Progenitors by Substance P: an Understanding of the Effects of a Neurotransmitter on the Differentiating Hematopoietic Stem Cell.

Effects Of Sp(1-4) On Cobblestone-Forming Cells. Implications For Endopeptidases As Hematopoietic Regulators

Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P

Negative Feedback on the Effects of Stem Cell Factor on Hematopoiesis is Partly Mediated Through Neutral Endopeptidase Activity on Substance P: a Combined Functional and Proteomic Study

Induction of Hypoxia-Inducible Factor-1Alpha and Activation of Caspase-3 in Hypoxia-Reoxygenated Bone Marrow Stroma is Negatively Regulated by the Delayed Production of Substance P.

Expression of Prolactin Receptor and Response to Prolactin Stimulation of Human Nk Cell Lines

Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells

Neuroimmune/Hematopoietic Axis with Distinct Regulation by the High-Mobility Group Box 1 in Association with Tachykinin Peptides.

Cytokine-Induced Suppression Of Medial Preoptic Neurons Mechanisms And Neuroimmunomodulatory Effects

Protein Tyrosine Phosphatase Receptors N and N2 Control Pituitary Melanotroph Development and POMC Expression

Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis

Endotoxin-stimulated release of cytokines by cultured cells from the murine neurohypophysis: role of dexamethasone and indomethacin

Alterations in the profile of blood neutrophil membrane receptors caused by in vivo adrenocorticotrophic hormone actions

Immunologic and Hematopoietic Effects of Recombinant Human Prolactin after Syngeneic Bone Marrow Transplantation in Mice.

Prolactin Modulates the Functions of Murine Spleen CD11c-positive Dendritic Cells